Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$12.66
-0.30-2.35%
At close: -
$13.13
0.473.71%
After Hours: 5:57 PM EDT
Comments
Loading...
Korro Bio Analyst Ratings and Price Targets | NASDAQ:KRRO | Benzinga
Korro Bio Inc has a consensus price target of $107.44 based on the ratings of 10 analysts. The high is $180 issued by Piper Sandler on March 27, 2024. The low is $25 issued by Chardan Capital on May 13, 2025. The 3 most-recent analyst ratings were released by Chardan Capital, Oppenheimer, and HC Wainwright & Co. on May 13, 2025, May 13, 2025, and May 8, 2025, respectively. With an average price target of $71.67 between Chardan Capital, Oppenheimer, and HC Wainwright & Co., there's an implied 445.82% upside for Korro Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
Oppenheimer
HC Wainwright & Co.
Cantor Fitzgerald
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Korro Bio
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
05/13/2025 | 90.4% | Chardan Capital | $25 → $25 | Maintains | Buy | |||
05/13/2025 | 585.45% | Oppenheimer | $155 → $90 | Maintains | Outperform | |||
05/08/2025 | 661.61% | HC Wainwright & Co. | $115 → $100 | Maintains | Buy | |||
04/29/2025 | 463.59% | Cantor Fitzgerald | → $74 | Initiates | → Overweight | |||
04/16/2025 | 90.4% | Chardan Capital | → $25 | Initiates | → Buy | |||
03/20/2025 | 775.86% | HC Wainwright & Co. | $115 → $115 | Reiterates | Buy → Buy | |||
03/19/2025 | 623.53% | RBC Capital | $105 → $95 | Maintains | Outperform | |||
11/22/2024 | 775.86% | HC Wainwright & Co. | $115 → $115 | Reiterates | Buy → Buy | |||
11/18/2024 | 890.1% | Jones Trading | → $130 | Initiates | → Buy | |||
11/13/2024 | 775.86% | HC Wainwright & Co. | $115 → $115 | Reiterates | Buy → Buy | |||
10/21/2024 | 699.7% | RBC Capital | $95 → $105 | Maintains | Outperform | |||
10/21/2024 | 1065.27% | Raymond James | → $153 | Initiates | → Strong Buy | |||
10/18/2024 | 775.86% | HC Wainwright & Co. | $100 → $115 | Maintains | Buy | |||
09/19/2024 | 623.53% | RBC Capital | $95 → $95 | Reiterates | Outperform → Outperform | |||
09/17/2024 | 661.61% | HC Wainwright & Co. | $100 → $100 | Reiterates | Buy → Buy | |||
08/14/2024 | 623.53% | RBC Capital | $105 → $95 | Maintains | Outperform | |||
08/14/2024 | — | William Blair | — | Initiates | → Outperform | |||
08/14/2024 | 661.61% | HC Wainwright & Co. | $100 → $100 | Reiterates | Buy → Buy | |||
05/21/2024 | 661.61% | HC Wainwright & Co. | $100 → $100 | Reiterates | Buy → Buy | |||
05/15/2024 | 813.94% | BMO Capital | $120 → $120 | Maintains | Outperform | |||
05/15/2024 | 661.61% | HC Wainwright & Co. | $115 → $100 | Maintains | Buy | |||
03/28/2024 | 775.86% | HC Wainwright & Co. | $100 → $115 | Maintains | Buy | |||
03/27/2024 | 1270.91% | Piper Sandler | $180 → $180 | Maintains | Overweight | |||
03/27/2024 | 585.45% | RBC Capital | $70 → $90 | Maintains | Outperform | |||
03/26/2024 | 813.94% | BMO Capital | $120 → $120 | Reiterates | Outperform → Outperform | |||
03/12/2024 | 433.13% | RBC Capital | $70 → $70 | Reiterates | Outperform → Outperform | |||
02/27/2024 | 813.94% | BMO Capital | → $120 | Initiates | → Outperform | |||
01/19/2024 | 661.61% | HC Wainwright & Co. | $100 → $100 | Reiterates | Buy → Buy | |||
12/04/2023 | 661.61% | HC Wainwright & Co. | → $100 | Initiates | → Buy | |||
11/29/2023 | 433.13% | RBC Capital | → $70 | Initiates | → Outperform | |||
11/10/2023 | 1270.91% | Piper Sandler | → $180 | Initiates | → Overweight |
FAQ
What is the target price for Korro Bio (KRRO) stock?
The latest price target for Korro Bio (NASDAQ:KRRO) was reported by Chardan Capital on May 13, 2025. The analyst firm set a price target for $25.00 expecting KRRO to rise to within 12 months (a possible 90.40% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Korro Bio (KRRO)?
The latest analyst rating for Korro Bio (NASDAQ:KRRO) was provided by Chardan Capital, and Korro Bio maintained their buy rating.
When was the last upgrade for Korro Bio (KRRO)?
There is no last upgrade for Korro Bio
When was the last downgrade for Korro Bio (KRRO)?
There is no last downgrade for Korro Bio.
When is the next analyst rating going to be posted or updated for Korro Bio (KRRO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Korro Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Korro Bio was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating Korro Bio (KRRO) correct?
While ratings are subjective and will change, the latest Korro Bio (KRRO) rating was a maintained with a price target of $25.00 to $25.00. The current price Korro Bio (KRRO) is trading at is $13.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
